Published in Cancer Weekly, May 11th, 2010
The focus of the presentation is on the progress Power3 and StemTroniX have made towards enhanced effectiveness of Alzheimer's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.